How Oncologists and Pathologists Can Best Collaborate to Provide Precision Medicine for Their PatientsVideo Categories: 2018 ASCO Insights and Video Library
Dr David Spigel discusses how medical oncologists and the rest of the cancer care team can best communicate with pathologists to help make informed treatment decisions for individual patients and set up new assays for emerging biomarkers as they are discovered.
Laura C. Michaelis, MD, Medical College of Wisconsin describes the approach of treating polycythemia vera with hydoxyurea.Supported through funding from Incyte
Drs. Geoffrey Oxnard and Lauren Ritterhouse consider the current landscape of reimbursement for molecular biomarker testing, the need to run FDA-approved tests, and the role of CMS and local Medicare providers in testing reimbursement.